Press release
Preclinical Brain Imaging Market Scope and Opportunities Analysis 2018 – 2026 // key player - Spectral Instruments Imaging, SIMTICS Ltd., Biodex Medical Systems Inc., MR Solutions, Aspect Imaging
The development of integrated systems that includes multiple functionalities, e.g., molecular and structural imaging are in demand and is expected to boost the growth of the Preclinical Brain Imaging Market. Due to technological advancements the companies are constantly upgrading their product offerings, for instance, Medisco Ltd. has launched integrated preclinical whole body PET/ MRI system, which has multi-cell anesthesia imaging bed and high throughput screening, and easy installation makes it popular among the users.Request TOC of this Report- https://www.factmr.com/connectus/sample?flag=T&rep_id=2562
Preclinical imaging is a technique used to monitor animals for research purposes such as in new drug development. Preclinical imaging includes many different imaging modalities, in which only few are suitable for imaging small animals, and others can be used in large animals. Preclinical imaging is used by researchers in visualizing changes in animal’s molecular, tissue and organ system. Preclinical brain imaging is a method to scan and visualize the neurological activity during preclinical study. Preclinical brain imaging is categorized into structural imaging and functional imaging. Structural brain imaging scans the structure of large intracranial organs and functional imaging is majorly used in diagnosis of metabolic disorders. Preclinical brain imaging modalities with non-invasive imaging techniques such as position emission tomography (PET) and single photon emission computed tomography (SPECT) are used for this purposes. The preclinical brain imaging is further used to observe the treatment response for early signals. Preclinical brain imaging is done using advanced high frequency ultrasound by using techniques such as Computed tomography (CT) and Magnetic resonance imaging (MRI). The most used preclinical brain imaging technique is PET+CT (x-ray computed tomography).
Browse Full Report with TOC- https://www.factmr.com/report/2562/preclinical-brain-imaging-market
According to a report of the National Brain tumor Society it is estimated that nearly 700,000 Americans are living with a brain tumor and cases of brain tumor will increase gradually in the recent years. The growing prevalence of brain cancer all around the globe laterally with increasing incidence rate of neurodegenerative disorders is expected to fuel the growth of the global preclinical brain imaging market. Due to technological advancements players are majorly focusing on product innovation for improving product portfolio, which creates growth opportunities for them in the preclinical brain imaging market. Increase in research and developmental activities and increasing governmental funding for research purposes are expected to drive the growth of preclinical brain imaging market. However, the high cost of the imaging technique is one of the major restraining factors in the growth of the global preclinical brain imaging market.
Tentatively, the global preclinical brain imaging market can be segmented on the basis of imaging type, end user and geography.
Based on imaging type, the global preclinical brain imaging market is segmented as:
Computed Tomography (CT)
Positron Emission Tomography (PET)
Magnetic resonance imaging (MRI)
single photon emission computed tomography (SPECT)
Based on end user, the global preclinical brain imaging market is segmented as:
Pharmaceutical Companies
Contract research organization (CRO’s)
Biotech Companies
Research Institutes
PET-CT preclinical imaging device is used in nuclear medicine procedures for detecting brain tumor, brain disorders, Alzheimer’s and other diseases. This preclinical brain imaging method also determine the effectivity of the drug treatment and reduces the need for unnecessary surgical procedures as the preclinical brain imaging scanner can determine the tissue mass. The advance features of the new age preclinical brain imaging scanners have increased their adoption and is expected to drive the growth of the preclinical brain imaging market over the forecast period. Among the end users, the pharmaceutical companies and CRO segments are expected to hold significant shares in the global preclinical brain imaging market.
Geographically, the global preclinical brain imaging market is segmented into North America, Latin America, Europe, CIS & Russia, Asia-Pacific excluding Japan (APEJ), Japan and the Middle East & Africa (MEA). North America is expected to be the dominant regional market for preclinical brain imaging, followed by Europe due to growing health care awareness among population and growing research and development activities. Asia Pacific is expected to grow at a higher rate as the leading market players are investing in the emerging markets. MEA preclinical brain imaging market is projected to grow at a moderate rate over the forecast period.
Examples of some of the key players operating in the global preclinical brain imaging market are Pure Imaging Phantoms, Bruker Corporation, Mediso Ltd., Spectral Instruments Imaging, SIMTICS Ltd., Biodex Medical Systems, Inc., MR Solutions, Aspect Imaging, TriFoil Imaging, and Caliber Imaging & Diagnostics, Inc., among others.
The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.
Request Brochure of this Report- https://www.factmr.com/connectus/sample?flag=B&rep_id=2562
About FactMR
FactMR is a fast-growing market research firm that offers the most comprehensive suite of syndicated and customized market insights reports. We believe transformative intelligence can educate and inspire businesses to make smarter decisions. We know the limitations of the one-size-fits-all approach; that's why we publish multi-industry global, regional, and country-specific research reports.
Contact Us
FactMR
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Email: sales@factmr.com
Web: https://www.factmr.com/
Read Industry News at - https://www.industrynewsanalysis.com/
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Preclinical Brain Imaging Market Scope and Opportunities Analysis 2018 – 2026 // key player - Spectral Instruments Imaging, SIMTICS Ltd., Biodex Medical Systems Inc., MR Solutions, Aspect Imaging here
News-ID: 1715249 • Views: …
More Releases from Fact.MR

Triple Negative Breast Cancer Treatment Market is Growing at a CAGR of 4.6% by 2 …
Fact.MR today unveiled its latest report on the Triple Negative Breast Cancer Treatment Market, projecting steady yet impactful growth amid rising global breast cancer incidences and a push for innovative therapies targeting this aggressive subtype. Valued at USD 670.5 million in 2024, the global market is forecasted to expand at a compound annual growth rate (CAGR) of 4.6%, reaching USD 1.04 billion by 2034. This expansion underscores the urgent need…

Pulmonary Fibrosis Treatment Market: U.S. to Grow to US$ 4.06 Billion by 2034, L …
The global pulmonary fibrosis treatment market is poised for steady expansion, with its valuation projected to grow from USD 3,210 million in 2025 to USD 5,890 million by 2035. This growth reflects a compound annual growth rate (CAGR) of 6.2% over the forecast period from 2025 to 2035. The surge is primarily driven by the increasing prevalence of idiopathic pulmonary fibrosis (IPF), rising awareness of early diagnosis, and advancements in…

Spices and Seasonings Market is Projected to Reach USD 23.6 Billion by 2035 | Mc …
The global spices and seasonings market is set for significant growth, projected to expand from USD 14.5 billion in 2025 to USD 23.6 billion by 2035, achieving an absolute increase of USD 8.3 billion and a 57.2% overall growth. This trajectory reflects a compound annual growth rate (CAGR) of 5.0% over the forecast period from 2025 to 2035, representing a 1.57X market size increase. The expansion is driven by rising…

Accounting Services Market: U.S. to Grow to US$ 640.73 Billion by 2034 at 10.3% …
The global accounting services market is positioned for substantial growth, with its valuation projected to increase from USD 650 billion in 2025 to USD 1,250 billion by 2035. This expansion reflects a compound annual growth rate (CAGR) of 6.7% over the forecast period from 2025 to 2035.
The market's surge is driven by the increasing complexity of financial regulations, the digital transformation of businesses, and the rising demand for outsourced…
More Releases for Preclinical
Driving Preclinical CRO Market Growth in 2025: The Role of Surging Demand For Pr …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
Preclinical CRO Market Size Growth Forecast: What to Expect by 2025?
In recent times, there has been a significant increase in the size of the preclinical CRO market. The market will develop from being worth $5.7 billion in 2024 to achieving a value of $6.26 billion the following year,…
DLL3 Inhibitors in Preclinical and Clinical Studies
Delta-Like Ligand 3 (DLL3) inhibitors have shown significant promise in preclinical and clinical studies, particularly for the treatment of aggressive cancers such as small cell lung cancer (SCLC) and neuroendocrine tumors. The selective expression of DLL3 in these malignancies makes it an attractive target for therapeutic intervention. This article explores the development and progress of DLL3 inhibitors in preclinical and clinical studies, highlighting their potential in modern oncology.
Download Report:
https://www.kuickresearch.com/report-dll3-targeted-therapies-dll3-cancer-therapies-dll3-protien-dll3-cancer-drugs-delta-like-ligand-3-dll3-gene-dll3-expression-dll3-amgen-dll3-inhibitor
DLL3…
Preclinical CRO Market Size Forecast Between 2023-2032
The global market for Preclinical Contract Research Organizations (CROs) has witnessed substantial growth in recent years, driven by increasing outsourcing of preclinical research activities by pharmaceutical and biotechnology companies. In 2022, the market size reached USD 5.2 Billion and is projected to grow to USD 10.7 Billion by 2032, with a compound annual growth rate (CAGR) of 7.6% from 2023 to 2032. This article delves into the current trends, drivers,…
Preclinical Imaging Market Opportunity | Size | Research Report
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲- Preclinical Imaging Market was valued at USD 748.18 Million in 2023 and is projected to reach USD 1,109.10 Million by 2030, growing at a CAGR of 5.0% from 2024 to 2030.
The preclinical imaging market is being significantly driven by advancements in imaging modalities, such as MRI, PET, SPECT, CT, and optical imaging. These technologies provide researchers with non-invasive ways to visualize and study biological processes at the…
Preclinical Imaging Market - Transforming Research with Precision Imaging: Precl …
Newark, New Castle, USA: The "Preclinical Imaging Market" provides a value chain analysis of revenue for the anticipated period from 2023 to 2031. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors
Preclinical Imaging Market: https://www.growthplusreports.com/report/preclinical-imaging-market/7673
This latest report researches the industry structure, sales, revenue,…
Preclinical Imaging Market - Unlocking Clarity, Preserving Scientific Excellence …
Newark, New Castle, USA - new report, titled Preclinical Imaging Market The report has been put together using primary and secondary research methodologies, which offer an accurate and precise understanding of the Preclinical Imaging market. Analysts have used a top-down and bottom-up approach to evaluate the segments and provide a fair assessment of their impact on the global Preclinical Imaging market. The report offers an overview of the market, which…